Pila Pharma Overview
- Founded
-
2014

- Status
-
Public
- Employees
-
3

- Stock Symbol
-
PILA

- Investments
-
2
- Share Price
-
$0.27
- (As of Monday Closing)
Pila Pharma General Information
Description
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
STO
Primary Office
- Västergatan 1
- 211 21 Malmo
- Sweden
+46 073-903 00 00
Pila Pharma Timeline
Pila Pharma Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.27 | $0.26 | $0.18 - $0.55 | $4.86M | 18.4M | 9.2K | $0.06 |
Pila Pharma Financials Summary
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 4,232 | 8,371 | ||
Revenue | 197 | 84 | 0 | 37 |
EBITDA | (1,657) | (1,998) | (755) | (914) |
Net Income | (1,657) | (2,004) | (757) | (917) |
Total Assets | 780 | 3,515 | 654 | 850 |
Total Debt | 0 | 0 | 61 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Pila Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Pila Pharma Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel ty
Drug Discovery
Malmo, Sweden
3
As of 2022
000
00.00
0000-00-00
00000000
000
Pila Pharma Competitors (10)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Biogen | Formerly VC-backed | Cambridge, MA | 0000 | 000.00 | 000000&0 | |
000000 | Formerly PE-Backed | Bengaluru, India | 00000 | 000.00 | 00000000 | 000.00 |
000000 00000000000 | Corporation | Boston, MA | 00 | 000.00 | 000000000000 | 000.00 |
000000 00000000 | Formerly VC-backed | Foster City, CA | 00000 | 00.000 | 000000000 | 00.000 |
000000000 | Formerly VC-backed | South San Francisco, CA | 00000 | 000.00 | 0000000000 |
Pila Pharma Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Dorte Gram Ph.D | Founder, Chief Executive Officer & Board Member | ||
Elna Åström | Chief Financial Officer | ||
Gustav Gram | Manager of Investor Relations |
Pila Pharma Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
Dorte Gram Ph.D | Pila Pharma | Founder, Chief Executive Officer & Board Member | 000 0000 |
Fredrik Buch MD | Self | Chairman | 000 0000 |
Lene Andersen | Pila Pharma | Board Member | 000 0000 |
Milan Zdravkovic Ph.D | Self | Board Member | 000 0000 |
Tyge Korsgaard | Self | Board Member | 000 0000 |
Pila Pharma Signals
Pila Pharma Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Pila Pharma Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 | 27-Sep-2016 | 00000 0000 | 00.000 | Drug Discovery | |
Ario Pharma (TRPV1 antagonist asset) | 30-Mar-2016 | Corporate Asset Purchase | Buildings and Property | 00000 000 |